LETTER
Conjugate Radical Additions to a,b-Unsaturated 2-Pyridyl Ketones
87
1999, 121, 8959. (f) Sammis, G. M.; Jacobsen, E. N. J. Am.
Chem. Soc. 2003, 125, 4442. Pyrazolidinones: (g) Sibi, M.
Compound 3a
Colorless liquid. The enantiomeric purity was determined by
HPLC analysis (254 nm, 25 °C): tR(minor) = 13.8 min;
tR(major) 15.0 min [Chiracel AD-H (0.46 cm × 25 cm; from
Daicel Chemical Ind., Ltd.) hexane–i-PrOH (99:1), 0.5 mL/
min] as 64% ee. [a]D25 14.2 (c 1.39, CH2Cl2). 1H NMR (500
MHz, CDCl3): d = 0.84 (d, J = 6.5 Hz, 3 H), 1.02 (d, J = 6.5
Hz, 3 H), 1.95–1.99 (m, 1 H), 3.21–3.25 (m, 1 H), 3.61 (dd,
J = 17.5, 5.0 Hz, 1 H), 3.77 (dd, J = 17.5, 9.5 Hz, 1 H), 7.12–
7.22 (m, 3 H), 7.22–7.40 (m, 2 H), 7.41–7.43 (m, 1 H), 7.73–
P.; Stanley, L. M.; Nie, X.; Venkatraman, L.; Liu, M.;
Jasperse, C. P. J. Am. Chem. Soc. 2007, 129, 395.
(4) For a study on achiral templates in Diels–Alder reactions,
see: Sibi, M. P.; Chen, J.; Stanley, L. Synlett 2007, 298.
(5) Acyl imidazoles: (a) Evans, D. A.; Fandrick, K. R.; Song,
H.-J. J. Am. Chem. Soc. 2005, 127, 8942. (b) Evans, D. A.;
Fandrick, K. R. Org. Lett. 2006, 8, 2249. (c) Evans, D. A.;
Song, H.-J.; Fandrick, K. R. Org. Lett. 2006, 8, 3351.
(6) a-Hydroxy ketones: (a) Palomo, C.; Oiarbide, M.; Kardak,
B. G.; Garcia, J. M.; Linden, A. J. Am. Chem. Soc. 2005,
127, 4154. (b) Palomo, C.; Oiarbide, M.; Garcia, J. M.;
Gonzalez, A.; Arceo, E. J. Am. Chem. Soc. 2003, 125,
13942.
(7) Aza chalcones: (a) Matsumoto, K.; Jitsukawa, K.; Masuda,
H. Tetrahedron Lett. 2005, 46, 5687. (b) Otto, S.;
Boccaletti, G.; Engberts, J. B. F. N. J. Am. Chem. Soc. 1998,
120, 4238. (c) Wittkopp, A.; Schreiner, P. R. Chem. Eur. J.
2003, 9, 407. (d) Rispens, T.; Engberts, J. B. F. N. J. Org.
Chem. 2002, 67, 7369. (e) Otto, S.; Engberts, J. B. F. N.;
Kwak, J. C. T. J. Am. Chem. Soc. 1998, 120, 9517.
(8) For selected reviews on enantioselective radical reactions,
see: (a) Sibi, M. P.; Manyem, S.; Zimmerman, J. Chem. Rev.
2003, 103, 3263. (b) Zimmerman, J.; Sibi, M. P. Top. Curr.
Chem. 2006, 263, 107. (c) Sibi, M. P.; Porter, N. A. Acc.
Chem. Res. 1999, 32, 163.
7.76 (m, 1 H), 7.89–7.91 (m, 1 H), 8.68–8.69 (m, 1 H). 13
C
NMR (125 MHz, CDCl3): d = 20.5, 20.8, 33.5, 41.1, 47.6,
121.8, 125.9, 126.9, 127.9, 128.5, 136.7, 143.9, 148.8,
153.6, 201.0. IR (neat): 995, 1641, 1697, 2960, 3426 cm–1.
ESI-HRMS: m/z calcd for C17H19NONa+: 276.1364; found:
276.1349.
Compound 3b
Colorless liquid. The enantiomeric purity was determined by
HPLC analysis (254 nm, 25 °C): tR(minor) = 14.9 min;
tR(major) = 17.9 min [Chiracel AD-H (0.46 cm × 25 cm;
from Daicel Chemical Ind., Ltd.) hexane–i-PrOH (99:1) 0.5
mL/min] as 66% ee. [a]D25 13.8 (c 1.11, CH2Cl2). 1H NMR
(500 MHz, CDCl3): d = 0.79 (d, J = 6.5 Hz, 3 H), 0.98 (d,
J = 6.5 Hz, 3 H), 1.88–1.93 (m, 1 H), 3.14–3.18 (m, 1 H),
3.52 (dd, J = 17.5, 5.0 Hz, 1 H), 3.73 (dd, J = 17.5, 5.0 Hz, 1
H), 7.14 (d, 3 H), 7.19 (d, 3 H), 7.42–7.45 (m, 1 H), 7.75–
7.88 (m, 1 H), 7.89–7.90 (m, 1 H), 8.66–8.67 (m, 1 H). 13
C
(9) Enantioselective conjugate radical additions using different
achiral templates. For oxazolidinones, see: (a) Sibi, M. P.;
Ji, J.; Wu, J. H.; Gurtler, S.; Porter, N. A. J. Am. Chem. Soc.
1996, 118, 9200. Imides: (b) Sibi, M. P.; Petrovic, G.;
Zimmerman, J. J. Am. Chem. Soc. 2005, 127, 2390.
Pyrazoles: (c) Sibi, M. P.; Shay, J. J.; Ji, J. Tetrahedron Lett.
1997, 38, 5955. Pyrazolidinones: (d) Sibi, M. P.;
NMR (125 MHz, CDCl3): d = 20.3, 20.7, 33.4, 41.0, 47.1,
121.8, 127.0, 128.0, 129.8, 131.6, 136.8, 142.3, 148.8,
153.4, 200.8. IR (neat): 996, 1490, 1584, 1642, 1697, 2959,
3431 cm–1. ESI-HRMS: m/z calcd for C17H18ClNONa+:
310.0975; found: 310.0962.
Compound 3g
Colorless liquid. The enantiomeric purity was determined by
HPLC analysis (254 nm, 25 °C): tR(major) = 16.4 min;
tR(minor) = 18.9 min [Chiracel OJ-H (0.46 cm × 25 cm;
from Daicel Chemical Ind., Ltd.) hexane–i-PrOH (99:1), 0.5
mL/min] as 43% ee. [a]D25 1.0 (c 0.87, CH2Cl2). 1H NMR
(400 MHz, CDCl3): d = 0.85 (d, J = 6.0 Hz, 3 H), 0.87 (d,
J = 6.0 Hz, 3 H), 1.24–1.30 (m, 1 H), 1.32–1.44 (m, 1 H),
1.60 (dt, J = 8.0, 7.6 Hz, 2 H), 1.74–1.78 (m, 1 H), 2.08–2.13
(m, 1 H), 2.56 (t, J = 7.6 Hz, 2 H), 3.08 (dd, J = 16.8, 6.1 Hz,
1 H), 3.15 (dd, J = 16.8, 6.1 Hz, 1 H), 7.11–7.14 (m, 3 H),
7.20–7.24 (m, 2 H), 7.42–7.45 (m, 1 H), 7.78–7.83 (m, 1 H),
8.00 (d, J = 7.6 Hz, 1 H), 8.65–8.67 (m, 1 H). 13C NMR (100
MHz, CDCl3): d = 18.7, 19.6, 29.3, 30.0, 31.2, 36.1, 38.9,
39.3, 121.8, 125.5, 126.9, 128.2, 128.3, 136.8, 142.7, 148.8,
153.8, 202.4. IR (neat): 995, 1583, 1642, 1692, 2957, 3431
cm–1. ESI-HRMS: m/z calcd for C20H25NONa+: 318.1834;
found: 318.1814.
Prabagaran, N. Synlett 2004, 2421. Naphthosultams:
(e) Sibi, M. P.; Sausker, J. B. J. Am. Chem. Soc. 2002, 124,
984. Pyrones: (f) Sibi, M. P.; Zimmerman, J. J. Am. Chem.
Soc. 2006, 128, 13346.
(10) Lee, S.; Lim, C. J.; Kim, S.; Subramaniam, R.; Zimmerman,
J.; Sibi, M. P. Org. Lett. 2006, 8, 4311.
(11) (a) de Vries, A. H. M.; Meetsma, A.; Feringa, B. L. Angew.
Chem., Int. Ed. Engl. 1996, 35, 2374. (b) G u, C.-L.; Liu, L.;
Sui, Y.; Zhao, J.-L.; Wang, D.; Chen, Y.-J. Tetrahedron:
Asymmetry 2007, 18, 455. (c) Zhang, Z.; Dong, Y.-w.;
Wang, G.-w.; Komatsu, K. Synlett 2004, 61.
(12) All new compounds showed analytical and spectral
characteristics consistent with their structure. An experi-
mental procedure and spectral data for select products are
provided.
General Procedure for Conjugate Radical Addition
A solution of the appropriate Lewis acid (0.06 mmol) and
bisoxazoline ligand (0.06 mmol) in CH2Cl2 (3 mL) was to
stirred at r.t. for 30 min under N2. Then, the substrate (0.20
mmol) in CH2Cl2 (1 mL) was added. After stirring for
another 30 min, the solution was cooled to –78 °C in a dry
ice–acetone bath. To the solution was added the radical
precursor RX (2.0 mmol), Bu3SnH (1.0 mmol), and Et3B
(1.0 M in hexane, 1.0 mL, 1.0 mmol) at –78 °C. A 10 mL
aliquot of O2 was then added via syringe. The reaction
mixture was stirred at –78 °C for the time shown in Table 3.
After completion (TLC), ethylenediamine tetraacetic acid
disodium salt solution (1.0 M in H2O, 10 mL) was added to
the reaction mixture. It was then extracted with CH2Cl2 (2 ×
30 mL) and dried with Na2SO4. The crude product was
purified by flash column chromatography to yield the
alkylated products.
Compound 3h
Colorless liquid. The enantiomeric purity was determined by
HPLC analysis (254 nm, 25 °C): tR(minor) = 21.2 min;
tR(major) = 23.9 min [Chiracel AD-H (0.46 cm × 25 cm;
from Daicel Chemical Ind., Ltd.) hexane–i-PrOH (99:1), 0.5
mL/min] as 69% ee. [a]D25 2.9 (c 1.00, CH2Cl2). 1H NMR
(500 MHz, CDCl3): d = 0.81 (t, J = 7.5 Hz, 3 H), 1.62–1.65
(m, 1 H), 1.72–1.76 (m, 1 H), 3.19–3.22 (m, 1 H), 3.49 (dd,
J = 17.5, 4.5 Hz, 1 H), 3.57 (dd, J = 17.5, 4.2 Hz, 1 H), 3.76
(s, 3 H), 6.80 (dd, J = 7.0, 2.5 Hz, 2 H), 7.16 (dd, J = 7.0, 2.5
Hz, 2 H), 7.41–7.44 (m, 1 H), 7.58–7.79 (m, 1 H), 7.93–7.95
(m, 1 H), 8.65–8.67 (m, 1 H). 13C NMR (125 MHz, CDCl3):
d = 12.0, 29.7, 41.9, 44.4, 55.1, 113.6, 121.8, 126.9, 128.6,
136.8, 136.9, 148.8, 153.6, 157.8, 200.9. IR (neat): 995,
1035, 1247, 1512, 1584, 1612, 1640, 1691, 2961, 3436
cm–1. ESI-HRMS: m/z calcd for C17H19NO2Na+: 292.1313;
found: 292.1325.
Synlett 2008, No. 1, 83–88 © Thieme Stuttgart · New York